These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 80150)

  • 1. [Use of intravenous disopyramide in 126 cases of cardiac rhythm disorders (author's transl)].
    Ducloux G; Faivre G; Perrin A; Raynaud R; Canicave JC; Fauchier JP; Groussin P; Loire R; Saulnier JP
    Ann Cardiol Angeiol (Paris); 1978; 27(4):297-302. PubMed ID: 80150
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of disturbances of cardiac rhythm using intravenous disopyramide].
    Lisin N; Andriange M; Vandenbosch R; Carlier J
    Rev Med Liege; 1974 May; 29(9):256-64. PubMed ID: 4134825
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of intravenous disopyramide in acute cardiac arrhythmias.
    De Backer M; Stoupel E; Kahn RJ
    Eur J Clin Pharmacol; 1981 Jan; 19(1):11-8. PubMed ID: 6161824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Oral longterm therapy with disopyramide phosphate in patients with atrial and ventricular arrhythmias (author's transl)].
    Stauch M; Grewe N
    MMW Munch Med Wochenschr; 1977 Dec; 119(48):1563-6. PubMed ID: 74799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical studies of Norpace (Part X).
    Dreifus LS
    Angiology; 1975 Jan; 26(1 Pt 2):148. PubMed ID: 46728
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of intravenous disopyramide for the conversion of supraventricular tachyarrhythmias.
    Stewart DE; Ikram H
    N Z Med J; 1984 Mar; 97(751):148-50. PubMed ID: 6584758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and hemodynamic effects of disopyramide phosphate administered i.v. in cardiopathic subjects (author's transl)].
    Chiariello M; Santinelli V; Ferro G; Tari MG; Stanislao M; Condorelli M
    G Ital Cardiol; 1979; 9(9):975-83. PubMed ID: 520746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Action of injected disopyramide on ventricular arrhythmias and atrioventricular conduction].
    Vogel M; Desoutter P; Bellanger P; Motté G; Welti JJ
    Arch Mal Coeur Vaiss; 1976 Apr; 69(4):395-406. PubMed ID: 59581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical studies of Norpace (Part XI).
    Nisbet T
    Angiology; 1975 Jan; 26(1 Pt 2):149-53. PubMed ID: 46729
    [No Abstract]   [Full Text] [Related]  

  • 10. [On ajmaline treatment of heart rhythm disorders].
    Forster G; Holzmann M
    Schweiz Med Wochenschr; 1967 Feb; 97(6):185-93 contd. PubMed ID: 4174226
    [No Abstract]   [Full Text] [Related]  

  • 11. [Intravenously disopyramide phosphate administration for treatment of arrhythmias].
    Aquaro G; Belli R; Pavia M; Rey L; Ravera A; Possavino G; Idone P
    G Ital Cardiol; 1982; 12(7):509-19. PubMed ID: 7169147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Data on disopyridamide therapy of some arrhythmias].
    Perroni GB; Briguglio FS; Oddo A; Trovato G
    Minerva Med; 1977 Jun; 68(32):2271-4. PubMed ID: 69277
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical studies of Norpace. Summarizing remarks.
    Fowler NO
    Angiology; 1975 Jan; 26(1 Pt 2):154-5. PubMed ID: 1090216
    [No Abstract]   [Full Text] [Related]  

  • 14. The antiarrhythmic efficacy of intravenous therapy with disopyramide phosphate.
    Deano DA; Wu D; Mautner RK; Sherman RH; Ehsani AI; Rosen KM
    Chest; 1977 May; 71(5):597-606. PubMed ID: 856558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of intravenous disopyramide in the termination of supraventricular arrhythmias.
    Luoma PV; Kujala PA; Juustila HJ; Takkunen JT
    J Clin Pharmacol; 1978; 18(5-6):293-301. PubMed ID: 641217
    [No Abstract]   [Full Text] [Related]  

  • 16. [The treatment of acute cardiac dysrhythmias with atenolol (Tenormin) particularly after myocardial infarction (author's transl)].
    Schley G; Beckmann R; Hengstebeck W
    Z Kardiol; 1978 Apr; 67(4):280-8. PubMed ID: 77592
    [No Abstract]   [Full Text] [Related]  

  • 17. [Disopyramide (Rhythmodan) in disorders of ventricular excitability].
    Puech P
    Minerva Med; 1970 Sep; 61(71 Suppl):3763-8. PubMed ID: 4195356
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of cardiac rhythm disorders with beta-receptor-blocking agents].
    Schäfer N; Stauch M
    Med Klin; 1969 May; 64(22):1037-41. PubMed ID: 4184380
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use and results of treatment with phenytoin infusion concentrate (author's transl)].
    Hansen HW; Marquort B; Pelz W
    Dtsch Med Wochenschr; 1974 Oct; 99(40):1961-4. PubMed ID: 4137487
    [No Abstract]   [Full Text] [Related]  

  • 20. [Injectable mexiletine and disorders of the auricular rhythm].
    Richard M; Touminet MA; Revillon L
    Ann Cardiol Angeiol (Paris); 1983 Nov; 32(7):479-83. PubMed ID: 6197927
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.